Efficacy and safety of ultrasound-guided high-intensity focused ultrasound for uterine fibroids: a preliminary experience
- PMID: 31006301
- DOI: 10.1080/01443615.2019.1581740
Efficacy and safety of ultrasound-guided high-intensity focused ultrasound for uterine fibroids: a preliminary experience
Abstract
The objective of this prospective cohort study was to evaluate the therapeutic efficacy and safety of ultrasound-guided high-intensity focussed ultrasound (HIFU) in the treatment of uterine fibroids. Twenty premenopausal women with symptomatic fibroids underwent ultrasound-guided HIFU therapy. Twenty-two fibroids with a median baseline volume of 127.0 cm3 (range 18.5-481.2 cm3) were treated. The percentages fibroid volume reduction were 46.9 (range -8.8-73.1) at 1-month, 57.4 (-51.5-95.2) at 3-month, 60.1 (-18.9-97.8) at 6-month and 75.9 (-33.7-99.3) at 12-month, after treatment. The modified Uterine Fibroid Symptom and Quality of Life (UFS-QOL) scores were reduced by 40.7% (0-59.3%) at 3-month, 45.5% (0-70.4%) at 6-month and 44.9% (0-71.4%) at 12-month after treatment. Three patients required subsequent surgical interventions. No significant complications were encountered. Ultrasound-guided HIFU appears to be effective and safe for the treatment of symptomatic uterine fibroids in selected patients. Impact statement What is already known on this subject? Ultrasound-guided high-intensity focussed ultrasound (HIFU) is a relatively new uterine-sparing treatment for fibroids. Most clinical reports are from China, which suggest that this treatment is a safe and effective modality. However, in many other countries, HIFU treatment for fibroids, especially using ultrasound as image guidance, is still considered novel with limited clinical experience. What do the results of this study add? This preliminary report adds to our limited local experience on HIFU and provides reassurance on our continual utilisation of this treatment modality for fibroids. With the increasing demand of uterine-sparing alternatives, experiences shared among different countries are important to make this treatment modality generalisable and universally acceptable. What are the implications of these findings for clinical practice and/or further research?Ultrasound-guided HIFU (USgHIFU) can potential be offered as an alternative treatment modality for women with fibroids.
Keywords: Fibroid; high-intensity focussed ultrasound; ultrasound-guided.
Similar articles
-
Ultrasound-guided high-intensity focused ultrasound for symptomatic uterine fibroids: clinical outcome of two European centers.Eur Radiol. 2025 Jun;35(6):3638-3648. doi: 10.1007/s00330-024-11230-4. Epub 2024 Nov 29. Eur Radiol. 2025. PMID: 39613955 Free PMC article.
-
Ultrasound-Guided High Intensity Focused Ultrasound Ablation for Symptomatic Uterine Fibroids: Preliminary Clinical Experience.Ultraschall Med. 2020 Oct;41(5):550-556. doi: 10.1055/a-0891-0729. Epub 2019 Jun 25. Ultraschall Med. 2020. PMID: 31238385 English.
-
Ultrasound guided high intensity focused ultrasound (USgHIFU) ablation for uterine fibroids: Do we need the microbubbles?Int J Hyperthermia. 2015 May;31(3):233-9. doi: 10.3109/02656736.2015.1004134. Epub 2015 Mar 11. Int J Hyperthermia. 2015. PMID: 25758436 Clinical Trial.
-
Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis.Eur J Radiol. 2019 Nov;120:108700. doi: 10.1016/j.ejrad.2019.108700. Epub 2019 Oct 15. Eur J Radiol. 2019. PMID: 31634683
-
Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis.Ont Health Technol Assess Ser. 2015 Mar 1;15(4):1-86. eCollection 2015. Ont Health Technol Assess Ser. 2015. PMID: 26357530 Free PMC article. Review.
Cited by
-
Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis.Sci Rep. 2023 Jun 19;13(1):9903. doi: 10.1038/s41598-023-37096-y. Sci Rep. 2023. PMID: 37336924 Free PMC article.
-
Ultrasound-Guided High-Intensity Focused Ultrasound of Uterine Fibroids and Adenomyosis: An 11-Year Experience from a Single Center in Hong Kong.J Clin Med. 2024 Aug 14;13(16):4788. doi: 10.3390/jcm13164788. J Clin Med. 2024. PMID: 39200930 Free PMC article.
-
Physician Experience in Technical Success of Achieving NPVR ≥ 80% of High-Intensity Focused Ultrasound Ablation for Uterine Fibroids: A Multicenter Study.Front Med Technol. 2022 Mar 8;3:790956. doi: 10.3389/fmedt.2021.790956. eCollection 2021. Front Med Technol. 2022. PMID: 35345412 Free PMC article.
-
High-Intensity Focused Ultrasound Ablation of Uterine Fibroids: A Review.Cureus. 2023 Sep 4;15(9):e44680. doi: 10.7759/cureus.44680. eCollection 2023 Sep. Cureus. 2023. PMID: 37809132 Free PMC article. Review.
-
Ventral hernia after high-intensity focused ultrasound ablation for uterine fibroids treatment: A case report.World J Clin Cases. 2022 Oct 26;10(30):11204-11209. doi: 10.12998/wjcc.v10.i30.11204. World J Clin Cases. 2022. PMID: 36338202 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical